Loading...
Alvotech
ALVO•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$9.61
$0.45(4.91%)
Alvotech (ALVO) Financial Performance & Income Statement Overview
Review Alvotech’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
435.56%
↑ 435.56%
Operating Income Growth
119.63%
↑ 119.63%
Net Income Growth
57.98%
↑ 57.98%
Operating Cash Flow Growth
24.13%
↑ 24.13%
Operating Margin
21.97%
↑ 21.97%
Gross Margin
60.59%
↑ 60.59%
Net Profit Margin
16.49%
↑ 16.49%
ROE
-23.20%
↓ 23.20%
ROIC
13.13%
↑ 13.13%
Alvotech (ALVO) Income Statement & Financial Overview
Review Alvotech's (ALVO) income statement with detailed quarterly and annual figures.
Metric | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
---|---|---|---|---|
Revenue | $102.89M | $198.75M | $12.43M | $53.39M |
Cost of Revenue | $39.81M | $45.21M | $19.96M | $56.42M |
Gross Profit | $63.08M | $153.54M | -$7.53M | -$3.03M |
Gross Profit Ratio | $0.61 | $0.77 | -$0.61 | -$0.06 |
R&D Expenses | $33.57M | $47.61M | $49.87M | $58.01M |
SG&A Expenses | $16.88M | $14.07M | $15.49M | $18.001M |
Operating Expenses | $50.35M | $61.68M | $65.36M | $74.12M |
Total Costs & Expenses | $90.16M | $106.89M | $85.31M | $130.54M |
Interest Income | $77.37M | $80.04M | $783000.00 | $0.00 |
Interest Expense | $90.68M | $42.05M | $184.06M | $68.56M |
Depreciation & Amortization | $8.40M | $7.56M | $7.19M | $6.72M |
EBITDA | $138.22M | -$16.60M | -$33.91M | -$139.57M |
EBITDA Ratio | $1.34 | -$0.08 | -$5.29 | -$2.19 |
Operating Income | $12.73M | $91.87M | -$72.88M | -$77.15M |
Operating Income Ratio | $0.12 | $0.46 | -$5.86 | -$1.45 |
Other Income/Expenses (Net) | -$37.48M | -$15.07M | -$176.75M | -$231.65M |
Income Before Tax | -$24.75M | $76.80M | -$225.17M | -$308.80M |
Income Before Tax Ratio | -$0.24 | $0.39 | -$18.11 | -$5.78 |
Income Tax Expense | -$13.36M | $11.57M | -$6.44M | -$32.24M |
Net Income | -$11.39M | $65.22M | -$218.73M | -$276.56M |
Net Income Ratio | -$0.11 | $0.33 | -$17.60 | -$5.18 |
EPS | $0.00 | $0.25 | -$0.82 | -$1.04 |
Diluted EPS | $0.00 | $0.25 | -$0.82 | -$1.04 |
Weighted Avg Shares Outstanding | $0.00 | $258.67M | $266.82M | $266.82M |
Weighted Avg Shares Outstanding (Diluted) | $0.00 | $258.67M | $266.82M | $266.82M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan